Sartorius Aktiengesellschaft (ETR:SRT3)
Germany · Delayed Price · Currency is EUR | Market Cap | 13.24B -3.1% |
| Revenue (ttm) | 3.54B +4.7% |
| Net Income | 154.90M +84.4% |
| EPS | 2.24 +84.2% |
| Shares Out | 69.04M |
| PE Ratio | 95.57 |
| Forward PE | 57.95 |
| Dividend | 0.74 (0.35%) |
| Ex-Dividend Date | Mar 27, 2026 |
| Volume | 68,786 |
| Average Volume | 107,200 |
| Open | 214.00 |
| Previous Close | 214.60 |
| Day's Range | 213.70 - 220.90 |
| 52-Week Range | 175.95 - 267.70 |
| Beta | 1.45 |
| RSI | 47.77 |
| Earnings Date | Apr 23, 2026 |
About ETR:SRT3
Sartorius Aktiengesellschaft provides bioprocess solutions, and lab products and services worldwide. The company offers analytical solutions, such as biolayer interferometry systems, high-throughput screening by cytometry systems, process analytical technology and data analytics, cell selection and retrieval, live-cell imaging and analysis systems, and surface plasmon resonance systems; cell culture solutions, including bioreactors and fermenters, cell culture reagents, supplements and matrices, nucleic acid and delivery solutions, cell culture... [Read more]
Financial Performance
In 2025, ETR:SRT3's revenue was 3.54 billion, an increase of 4.66% compared to the previous year's 3.38 billion. Earnings were 154.90 million, an increase of 84.40%.
Financial StatementsNews
Dax Up Marginally; Sartorius Up Sharply On Raising Targets
(RTTNews) - German stocks are turning in a mixed performance on Tuesday as oil prices climbed higher amid an escalation in the ongoing conflict in the Middle East following reports of fresh attacks by...
Sartorius Shares Rise After Company Targets Top-Line, Profitability Growth
Sartorius Issues New Mid-term Financial Targets
(RTTNews) - Sartorius said, based on its assessment of future market development, the company expects its addressable markets to grow at a rate of approximately 7 to 9 percent per year over the medium...
SARTORIUS AG: Sartorius Launches Next-Generation Platform to Boost Efficiency in Cell Therapy Production
GOTTINGEN, GERMANY / ACCESS Newswire / March 16, 2026 / Sartorius launches next-generation platform to boost efficiency in cell therapy productionEveo Cell Therapy Platform enables automated, multi...
It's time to scoop up undervalued stocks in this critical sector of the economy
Expanding your horizons and considering neglected sectors can help you identify bargain opportunities while defending your investment portfolio from a stock-market decline.
Sartorius Shares Rise After Guidance Lift
Sartorius said it now expects 7% revenue growth for 2025, compared with 6% previously, as underlying net profit rose 17%.
Betting on Growth: 4 Favorite Stocks From T. Rowe Price's Peter Bates
The manager of the Global Select Equity Strategy looks for high margins, cash generation, competitive advantages, and a long runway of growth.
10 stocks for investors looking for ‘wonderful companies at a fair price'
As money managers talk about various methods of selecting quality companies, investors might also think about diversification, which can lower risk and broaden opportunities.
These 5 DAX index companies are in trouble as their stocks plunge
German stocks are not doing well as the economy goes through substantial challenges. The most recent data showed that business confidence has tumbled while manufacturing and services PMIs have remaine...
Sartorius, Sartorius Stedim shares fall after Polyplus acquisition
Shares in German pharmaceutical and laboratory equipment supplier Sartorius AG and its France-listed subsidiary Sartorius Stedim Biotech SA DIM, -6.51% fell in opening trade on Friday after the compan...